Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.
about
Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation.Gene therapy for liver cirrhosis.Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injuryExperimental models of hepatocellular carcinomaAcceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.Liver hyperplasia after tamoxifen induction of Myc in a transgenic medaka model.Targeting the HGF/c-MET pathway in hepatocellular carcinoma.Adeno-associated virus vector-mediated production of hepatocyte growth factor attenuates liver fibrosis in miceAdvances in antifibrotic therapy.Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET.Hepatitis B virus inhibits liver regeneration via epigenetic regulation of urokinase-type plasminogen activator.Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease.Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling.Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells.High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2.Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor.HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1.Regulation of the c-met proto-oncogene promoter by p53.Effects of hepatocyte growth factor on glutathione synthesis, growth, and apoptosis is cell density-dependent.Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acetylaminofluorene/partial hepatectomy model in rats.Reversing liver cirrhosis: impact of gene therapy for liver cirrhosis.Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.MicroRNA-7-5p mediates the signaling of hepatocyte growth factor to suppress oncogenes in the MCF-10A mammary epithelial cell.Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice.Effects of maternal parity and late gestational nutrition on mRNA abundance for growth factors in the liver of postnatal sheep
P2860
Q33183473-CB081691-8519-4AC7-A9FF-0BE7229056E3Q33888055-0F75ACFD-9DD8-40D1-B815-49218221D094Q33894802-B39EFD2A-B45C-4F3E-8B1C-57AE53313045Q34345987-659C5E7B-5113-450F-8C25-8B89E038C3E5Q35787087-C87EF684-5C4F-4568-913D-A89753CD1FC5Q35903501-AAB18052-FCC8-4596-9885-A4B77ACD6F7BQ36051061-1DF3D275-6B65-4D7E-8922-5CCED287026EQ36093497-3B4892E0-1FD2-43D5-A7F3-C3118BAA8A2FQ37278165-786DFEAF-4D94-414F-B304-89A5DD0F1D3BQ37353099-B4A01D42-ACE5-4962-9D30-3D68BF58EDF9Q37883394-C85963BD-2AC1-473F-93BB-01FCF3385E64Q39181943-42055177-BEE4-4662-B423-4E1F2DA198D2Q40086953-0967A63A-28BF-41D0-AFD7-E9A84DC2D4E2Q40148697-D291E563-948F-4562-AB5B-C87E09DF43C3Q40398127-7C62ED27-4EE2-4F0F-8320-B10B72E267B1Q40782695-A1EF439D-44E9-4C1D-B04A-801153848249Q40957403-80A200A0-6802-410E-AB8C-C4717C228D70Q40957637-F28A90DD-F6CF-4F72-8C58-BC64B327D805Q40977563-7953D89C-A5F8-4E4A-841D-D249188F36B8Q42125760-4A3A79BA-A1D0-45A1-957A-565E3930BF1CQ43919088-5B6B4561-93A0-4FE7-95E5-EDEA9C275780Q44032116-CAEBD895-62D9-4D8A-8EDD-4536DD33DFEDQ45859642-16452A0C-15B8-4FF6-AD7D-4FCA7C291A23Q45883662-14DB8DDD-6A66-432B-B146-AD28DB478DE2Q47107336-411EEA0B-4F8D-4F69-A221-C5B38D1D8435Q53387230-1080355A-A189-43E1-97EA-6DBA4FDC2101Q53426264-0E7D49CB-A6F1-44D5-8BDE-370E57B7D6A7Q58962399-4FA74509-16FD-4318-835C-3C152660DCD3
P2860
Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of neoplastic devel ...... r in a transgenic mouse model.
@en
Inhibition of neoplastic devel ...... r in a transgenic mouse model.
@nl
type
label
Inhibition of neoplastic devel ...... r in a transgenic mouse model.
@en
Inhibition of neoplastic devel ...... r in a transgenic mouse model.
@nl
prefLabel
Inhibition of neoplastic devel ...... r in a transgenic mouse model.
@en
Inhibition of neoplastic devel ...... r in a transgenic mouse model.
@nl
P2093
P2860
P356
P1476
Inhibition of neoplastic devel ...... r in a transgenic mouse model.
@en
P2093
Audolfsson T
Preisegger KH
Santoni-Rugiu E
Schmidt EV
Thorgeirsson SS
P2860
P304
P356
10.1073/PNAS.93.18.9577
P407
P577
1996-09-01T00:00:00Z